| 2937.21.00 | 40 | Prednisolone | g | | | |
| 2937.22.00 | 00 | Halogenated derivatives of adrenal cortical hormones | g | Free | | 25% |
| 2937.23.10 | | Obtained directly or indirectly from animal or vegetable materials | | Free | | 25% |
| 2937.29.90 | 30 | Salts and esters of prednisone | g | | | |
| 2937.29.90 | 40 | Salts and esters of prednisolone | g | | | |
| 2938 | | XII. GLYCOSIDES AND VEGETABLE ALKALOIDS, NATURAL OR REPRODUCED BY SYNTHESIS, AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES | | | | |
| 2938 | | Glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives: | | | | |
| 2939 | | Vegetable alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives: | | | | |
| 2939.41.00 | 00 | Ephedrines and their salts: | | | | |
| 2939.41.00 | 00 | Ephedrine and its salts | kg | Free | | 15.4￠/kg + 59% |
| 2939.42.00 | 00 | Pseudoephedrine and its salts | kg | Free | | 15.4￠/kg + 59% |
| 2939.51.00 | 00 | Theophylline and aminophylline (theophylline- ethylenediamine) and their derivatives; salts thereof: | | | | |
| 2941.90.30 | 00 | Aromatic or modified aromatic | kg | Free | | 15.4￠/kg + 45% |
| 2942.00.03 | 00 | Aromatic or modified aromatic: | | | | |
| 2942.00.10 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 46.5% |
| 3001 | | Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included: | | | | |
| 3001.90.01 | 10 | Glands and other organs, dried, whether or not powdered: | | | | |
| 3002 | | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: | | | | |
| 3002.10.01 | | Antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes | | Free | | Free |
| 3002.10.01 | 20 | Normal human blood sera, whether or not freeze-dried | kg | | | |
| 3002.20.00 | 00 | Vaccines for human medicine | kg | Free | | Free |
| 3002.30.00 | 00 | Vaccines for veterinary medicine | kg | Free | | Free |
| 3003 | | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale: | | | | |
| 3004 | | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: | | | | |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
